Esperion Therapeutics (ESPR) EGM 2026 summary

Opening remarks and agenda

• Chairperson called the meeting to order at 8:00 A.M. and outlined the rules of conduct and agenda.

• Notice of the meeting and proxy statement were distributed to stockholders of record as of May 28, 2026.

• Quorum was confirmed, with a majority of voting power present virtually or by proxy.

Specific resolutions to be voted on

• Approval of the Agreement and Plan of Merger with Essence Parent and Essence MergerCo, making the company a wholly owned subsidiary.

• Advisory vote on compensation for named executive officers in connection with the merger.

• Approval to adjourn the meeting if additional proxy solicitation was needed.

Overview of voting outcomes

• Merger Agreement Proposal was approved by a majority of outstanding shares.

• Advisory Compensation Proposal was approved by a majority of outstanding shares.

• Adjournment Proposal was not addressed as the merger was approved.

• Final vote counts to be reported in a Form 8-K filing within four business days.